Search
Morgan Stanley's Xing Ziqiang: China's Pharmaceutical Industry Will Reach Its "DeepSeek Moment" by 2040
1 week ago /
Read about 0 minute
Author：小编
Xing Ziqiang, Morgan Stanley's Chief China Economist, remarked that China is achieving remarkable strides in technological innovation, underpinned by three distinct competitive edges: well - developed industrial chain clusters, a rich pool of science and engineering talent, and an enormous market size—factors that are hard for other economies to replicate. He further emphasized that China's biopharmaceutical sector is undergoing explosive expansion. It is projected that by 2040, over one - third of the new drugs approved by the U.S. Food and Drug Administration (FDA) will originate from China, signifying a landmark achievement for the nation's pharmaceutical industry.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
